Mintz On Air

SPAC Chat Ep. 3: Tracking Trends of the SPAC Surge

There is no denying the surge in special purpose acquisition companies (SPACs) and that these financing vehicles have had a significant impact on financial markets. Join your favorite SPAC attorneys as they discuss the key trends highlighted in Mintz’s comprehensive new SPAC report produced in collaboration with PitchBook, Breaking Down the SPAC Surge: A Review of Key Trends & Issues Defining the Phenomenon.
 
Topics covered will include:
- The steady rise of capital
- Redefining company valuations
- The strength of the PIPE market
- Ever-evolving risks

Tom Burton, Jeff Schultz, Sahir Surmeli, and the Mintz team have handled some of the hottest multibillion-dollar SPAC transactions in recent months, including for XL Fleet, Butterfly Network, and Canaccord Genuity’s Environmental Impact Acquisition Corp. Mintz’s SPAC practice draws from decades of experience guiding clients in a broad spectrum of industries through the intricacies of SPAC financings. The firm handled the first New York Stock Exchange SPAC transaction and has completed over 35 SPAC transactions, including SPAC IPOs and de-SPAC mergers.

Health Law Diagnosed: Final Rules Amending the Anti-Kickback Statute and Stark Law Regulations: Part 2

At the end of 2020, the US Department of Health and Human Services Office of Inspector General and Centers for Medicare and Medicaid Services issued final rules modifying and expanding upon the regulatory safe harbors and exceptions to the federal Anti-Kickback Statute and the Stark Law, respectively.

In Part 2 of this two-part series, Mintz’s Karen Lovitch and Rachel Yount return to examine the changes to the Stark Law regulations, including new defined terms, modifications to existing exceptions, and the government’s efforts to ease compliance burdens associated with this strict liability statute.

SPAC Chat Ep. 2: The Controversy Over Sponsor Equity

Does a minimal investment in a Special Purpose Acquisition Company (SPAC) entitle a sponsor to a tremendous amount of equity after a successful IPO? Hypothetically speaking, will an investment of $25,000 for founder shares result in approximately $40 million of equity value upon completion of a $200 million SPAC IPO? What is at risk for SPAC sponsors and what are the controversies surrounding sponsor equity?

Join Mintz’s Thomas Burton, Sahir Surmeli, and Jeffrey Schultz for the second episode of SPAC Chat as they dive into the risks and high rewards affiliated with being a SPAC sponsor. Topics covered will include:

- What is sponsor equity?
- How much do sponsors typically get?
- What is at risk with investing?

Mintz has handled some of the hottest multibillion-dollar SPACs this season, including XL Fleet, Butterfly Network, and Canaccord Genuity’s Environmental Impact Acquisition Corp., and draws from decades of experience guiding clients through the intricacies of SPAC financings. Mintz handled the first New York Stock Exchange SPAC transaction and has completed over 35 SPAC transactions, including SPAC IPOs and de-SPAC mergers.

Health Law Diagnosed: Final Rules Amending the Anti-Kickback Statute and Stark Law Regulations: Part 1

At the end of 2020, the U.S. Department of Health and Human Services Office of Inspector General and Centers for Medicare and Medicaid Services issued final rules modifying and expanding upon the regulatory safe harbors and exceptions to the federal Anti-Kickback Statute and the Stark Law, respectively. In Part 1 of this two-part series, Mintz’s Karen Lovitch and Rachel Yount examine the changes to the Anti-Kickback safe harbors, and how they advance the government’s efforts to promote value-based care and reduce the regulatory burdens that impede care coordination.

SPAC Chat: Busting Common Myths about SPACs

Special Purpose Acquisition Companies (SPACs) are taking over Wall Street as more and more companies are taking advantage of this alternative IPO strategy. However, SPACs didn’t always have the best reputation, with many analysts warning against their growing popularity. Grab a cup of coffee and listen as leading SPAC attorneys from Mintz discuss and debunk the four most common myths about these transactions.

Tom Burton, Jeff Schultz, and Sa Surmeli have handled some of the hottest multibillion-dollar SPACs this season, including XL Fleet, Butterfly Network, and Canaccord Genuity’s Environmental Impact Acquisition Corp. Listen to them bust the following most common myths about SPACs:

1. SPAC is a four-letter word.
2. SPACs are the same as IPOs.
3. SPACs are faster and cheaper than traditional IPOs.
4. SPACs only enrich sponsors at the expense of others.

MintzEdge Entrepreneur Perspective: Carl Dumesle of HUGS on Launching a Start-Up as a Student

In this podcast, Sebastian Lucier speaks with Carl Dumesle, one of the winners of the USD School of Business Fowler Business Concept Challenge, about the experiences of launching a company as a student and engaging with academic institution resources available to student entrepreneurs.

Health Law Diagnosed: Bioethical Considerations in a Pandemic

Mounting anxiety over how to control the spread of infectious disease outbreaks encourages public and political discourse of bioethics. In the third episode of Mintz’s Health Law Diagnosed, Mintz’s Bridgette Keller talks about the legal, public health, and bioethics concerns inherent in a global pandemic, including allocating scarce medical resources such as COVID-19 vaccine, and how the greatest challenge to vaccine distribution may be the public’s hesitancy.

Health Law Diagnosed: Confronting Racial Disparities in Health Care: How Providers Can Drive Change

Despite dramatic improvements in the overall health of the population, racial and ethnic disparities in health and in our health care delivery system persist. In the second episode of Mintz’s Health Law Diagnosed, Dr. Tom Sequist of Mass General Brigham speaks to Mintz’s Brent Henry about what health care providers can do to help break down the barriers that perpetuate our country’s health care inequalities.